RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin. (Q40072914)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

Christopher D. Kontos

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Jing Mi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Xiuwu Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Zahid N Rabbani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Yingmiao Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Srinevas K Reddy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Zhen Su

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Fawzia K Salahuddin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Kristi Viles

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Paloma H Giangrande

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Mark W Dewhirst

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Bruce A Sullenger

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Bryan M Clary

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

2 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

66-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclines

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

NF-kappaB in cancer: a marked target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Apoptosis: a link between cancer genetics and chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Control of apoptosis by p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK/extracellular signal-regulated kinase/p90(rsk) signaling pathway in response to distinct forms of DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Anthracycline drug targeting: cytoplasmic versus nuclear--a fork in the road

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Adaptive recognition by nucleic acid aptamers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Yeast genetic selections to optimize RNA decoys for transcription factor NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Nuclear factor-kappa B and cancer: its role in prevention and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: an effective multi-faceted targeting of the tumor-cell phenotype?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Regulation and function of the p53 tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

NF-kappaB as a molecular target in adjuvant therapy of gastrointestinal carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Rationale for the treatment of solid tumors with the proteasome inhibitor bortezomib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Optimizing aptamer activity for gene therapy applications using expression cassette SELEX.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Cytoplasmic RNA modulators of an inside-out signal-transduction cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Complicating the complexity of p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

NF-kappaB at the crossroads of life and death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Role of NF-κB in p53-mediated programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300320

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17912235%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference